Biography

As a health economist with 10+ years of international experience in biomedicine, specializing in strategic health technology assessment (HTA), decision modelling and policy, I'm dedicated to improving patient access to innovative therapies. Throughout my career, I have led impactful health economic evaluations, evidence synthesis projects, and HTA submissions across industry, consultancy, and academia. These have directly contributed to successful drug approvals and enhanced access pathways.